- Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
Tijana Stanković et al, 2019, Current Medicinal Chemistry CrossRef - The role of dietary flavonoids for modulation of ATP binding cassette transporter mediated multidrug resistance
Hui Teng et al, 2021, eFood CrossRef - Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma
Keisuke Shigeta et al, 2020, Cancer Science CrossRef - Cepharanthine Regulates Autophagy via Activating the p38 Signaling Pathway in Lung Adenocarcinoma Cells
Chao Wang et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef - Pharmacological Activity of Cepharanthine
Ke Liu et al, 2023, Molecules CrossRef - Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial–Mesenchymal Transition in an Ovarian Tumor
Xi Chen et al, 2024, Journal of Natural Products CrossRef - Cajanol Sensitizes A2780/Taxol Cells to Paclitaxel by Inhibiting the PI3K/Akt/NF-κB Signaling Pathway
Ming Sui et al, 2021, Frontiers in Pharmacology CrossRef - Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways
Chuansheng Yang et al, 2022, Molecules CrossRef - Alkaloids Exhibit a Meaningful Function as Anticancer Agents by Restraining Cellular Signaling Pathways
Chong Guo et al, 2022, Mini-Reviews in Medicinal Chemistry CrossRef - Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway
Yang-yang Lu et al, 2023, Cell Death Discovery CrossRef - Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines
Chung-Pu Wu et al, 2020, Biochemical Pharmacology CrossRef - Pharmacological Effects and Clinical Prospects of Cepharanthine
Di Liang et al, 2022, Molecules CrossRef - PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
Alia Ghoneum et al, 2019, Cancers CrossRef - Unveiling the potential of Cepharanthine from plant to patient- A comprehensive review of phytochemistry, pharmacology and clinical investigations
Swati Dobhal et al, 2024, Journal of Biologically Active Products from Nature CrossRef - Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
Christian Bailly, 2019, Phytomedicine CrossRef - Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo et al, 2019, Chinese Medicine CrossRef - Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC)
Yao Wang et al, 2020, Expert Opinion on Therapeutic Targets CrossRef - A mechanistic updated overview on Cepharanthine as potential anticancer agent
YingZheng Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Overcoming P-Glycoprotein-Mediated Doxorubicin Resistance
Suree Jianmongkol, 2021, Advances in Precision Medicine Oncology CrossRef - Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review)
Yichen Tian et al, 2023, International Journal of Oncology CrossRef - Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
Rong Zhang et al, 2022, Brazilian Journal of Pharmaceutical Sciences CrossRef - Rhinacanthin-C enhances chemosensitivity of breast cancer cells via the downregulation of P-glycoprotein through inhibition of Akt/NF-kappa B signaling pathway
Suwichak Chaisit et al, 2021, Journal of Herbmed Pharmacology CrossRef - Paclitaxel and chemoresistance
Zhuo-Xun Wu et al, 2022, Paclitaxel CrossRef